Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
We’re building a world where complex diseases are prevented and cured, treatments are smarter and less invasive—and solutions are personal.
News
Johnson & Johnson Announces Data to Support Boosting its Single-Shot COVID-19 Vaccine
Johnson & Johnson COVID-19 vaccine booster, after single dose primary regimen, provided rapid and robust increase in spike-binding antibodies New studies build on data demonstrating strong durability through eight months after immunization
Read more
Report
Positive New Data for Johnson & Johnson Single-Shot COVID-19 Vaccine on Activity Against Delta Variant and Long-lasting Durability of Response
Demonstrated strong neutralizing antibody activity against the Delta (B.1.617.2) variant Persistent immune responses through at least eight months
Read more
Report
Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA For Emergency Use - First Single-Shot Vaccine in Fight Against Global Pandemic
Data demonstrated protection against COVID-19 related hospitalization and death, across countries with different variants Available on not-for-profit basis for emergency pandemic use Shipping vaccine immediately, delivering more than 20 million doses to U
Read more
Report
Johnson & Johnson Announces Submission of Application to the U.S. FDA for Emergency Use Authorization of its Investigational Single-Shot Janssen COVID-19 Vaccine Candidate
Johnson & Johnson intends to distribute vaccine to the U.S. government immediately following authorization, and expects to supply 100 million doses to the U.S. in the first half of 2021
Read more
Report
Pro access
Upgrade to see all 8 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
Growth
Hiring Momentum
33/100
Slowing
Open positions
0
0 opened / 0 closed in 30 days
Hiring Dynamics
0%
Activity Timeline
New location: Washington
Aug 2026